Notizia - Recent Pharma, Healthcare and Biotech Happenings

Atlas Venture raises USD 250 Million for investing in later-stage Massachusetts-based Atlas Venture has raised USD 250 million for later-stage investments. The fund will allow the VC shop to bolster its startups through series B and beyond. The early-stage operation has bolstered a couple of startups like Padlock and Unum Therapeutics, to IPOs and trade sales. Atlas Venture Opportunity Fund I (AVOF I) is the VC shop’s remedy for financial requirements. Atlas Venture has USD 250 million to support the portfolio companies as they reach series B and beyond. Harpoon files USD 86 Million IPO for funding its T-cell engager platform Harpoon Therapeutics declare...